Once inside the body, HIV persists because of its remarkable ability to hide within healthy CD4 T cells, where it can lie ...

GA2-immunized participants showed higher levels of polyfunctional CD4+ and Vδ2+ γδ T cells with an effector memory phenotype, ...

FBLG READ THE FULL FBLG RESEARCH REPORT Business Update On Track to Initiate Phase 1/2 Trial in Diabetic Foot Ulcers FibroBiologics, Inc. (NASDAQ:FBLG) is on track to initiate a Phase 1/2 trial of ...

Memory CD8 + T cells are the mature version that has encountered an antigen before and create an immune response if it is reencountered. Lower levels of apoptosis were also seen in the CD4 + T cells ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to ...

Results from a new animal study found that maternal exposure to e-cigarette residues, with or without nicotine, affected ...

The phase 2 CELLVX-230 trial is assessing the potential of FK-PC101 to prevent prostate cancer recurrence and delay ...

("Capstan"), a biotechnology company dedicated to advancing in vivo reprogramming of cells through RNA ... of conventional ex vivo CAR-T therapy. Calgary Health Foundation, a Calgary-based nonprofit ...

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

RNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than ...

Discover a study that investigated how vedolizumab affects the immune cells circulating in the blood, focusing on which ...